99
Participants
Start Date
December 16, 2009
Primary Completion Date
November 8, 2011
Study Completion Date
June 19, 2020
BIBF 1120
VEGF inhibitor
sunitinib
VEGF inhibitor
University of Pecs Medical School, Dept. of Oncotherapy, Pécs
Municipal Establishment Cherkasy Oncology Centre, Cherkasy
"Munic.Instit.City Clin.Hosp.#4 of Dnipro City Council", Dnipropetrovks
Bukovynsk State Medical University, Chernivtsi
CI of LRC Lviv Onco.Reg.Treat.&Diag.Cent., Lviv
Uzhgorod National University, Oncology Centre, Uzhhorod
Sf. Nectarie Oncology Center, Craiova, Craiova
ONCOLAB SRL, Craiova, Craiova
Ziemia Lubelska Oncological Center, Lublin, Lublin
Onco.Cent. - Instit. of Maria Sklodowskiej-Curie, Warsaw
Military Central Clinical Emergency Hospital, Bucharest
Addenbrooke's Hospital, Cambridge
Beatson West of Scotland Cancer Centre, Glasgow
Surrey Cancer Research Institute, Guildford
St James's University Hospital, Leeds
Lead Sponsor
Boehringer Ingelheim
INDUSTRY